EQT

eTheRNA immunotherapies NV specializes in the development of mRNA-based immunotherapies aimed at enhancing the human immune system's response to cancer and infectious diseases. The company's innovative TriMix technology specifically targets dendritic cells, which play a crucial role in initiating immune responses. By harnessing this technology, eTheRNA seeks to provide more effective and safer treatment options for patients with conditions such as melanoma and triple-negative breast cancer. Founded in 2013 and headquartered in Niel, Belgium, eTheRNA has established a strategic partnership with China Grand Pharmaceutical and Healthcare Holdings Limited to further its research and development efforts. The company is dedicated to advancing the field of immunotherapy to improve patient outcomes.

United Talent Agency (UTA) where they represent actors, writers, directors, recording artists, emerging technology companies, and corporate brands in a variety of industries, including film, television, music, digital media, intellectual property, computer and video games, commercials, voiceovers, endorsements, and entertainment marketing. Some of their clients are Johnny Depp, Harrison Ford, Owen Wilson, Gwyneth Paltrow, Jennifer Lopez, Paul Giamatti, Anthony Hopkins, Tim Robbins, Seth Rogen, James McAvoy, Ewan McGregor, Rachel McAdams, Paul Rudd, Don Cheadle, and Elizabeth Banks.

Xilis, Inc. is an oncology and precision health company that focuses on improving cancer diagnosis and treatment. Founded in 2019 and based in Chapel Hill, North Carolina, Xilis utilizes advanced organoid technologies, specifically micro-organoids, to create thousands of 3D replicas of a patient's tumor within six days. This innovative approach allows for rapid diagnostics and personalized drug screening, enabling healthcare providers to identify the most effective treatments for individual patients. The company's platform supports scalable, patient-derived models that facilitate high-throughput drug discovery, ultimately assisting physicians and pharmaceutical companies in developing tailored therapies at a reduced cost.

ImCheck Therapeutics SAS is a biopharmaceutical company based in Marseille, France, founded in 2015. The company specializes in the development of immunotherapeutics aimed at addressing severe unmet medical needs, primarily in the field of immuno-oncology. ImCheck focuses on creating immuno-modulatory antibodies that target members of the butyrophilin super-family of checkpoint molecules, specifically engaging γ9δ2 T cells. Its research and development efforts are directed toward treating various cancers, including breast, gastric, and ovarian cancers, as well as other immune-related diseases. The company's innovative approach positions it at the forefront of next-generation immunotherapy solutions for patients suffering from solid tumors.

Ariceum Therapeutics is a privately held radiopharmaceutical firm in the clinical stage that specializes in the detection and targeted treatment of aggressive malignancies, such as neuroendocrine and other hard-to-treat cancers. 177Lu-satoreotide tetraxetan (Satoreotide), the company's primary targeted systemic radiopharmaceutical therapy, is an antagonist of the somatostatin type 2 receptor (SSTR2), which is overexpressed in many neuroendocrine tumors. For the simultaneous diagnosis and targeted radionuclide treatment of neuroendocrine malignancies, some aggressive tumors, and childhood cancer, which currently offers few treatment choices and a poor prognosis, we are developing satoreotide as a "theranostic" pair.

Ardoq AS is a company that develops software solutions to assist organizations in documenting and managing complex computer systems and enterprise architecture. Founded in 2013 and based in Oslo, Norway, with additional offices in major cities like New York, London, and Copenhagen, Ardoq offers a data-driven platform that combines textual documentation with interactive visualizations. Its features include automatically generated diagrams, real-time collaboration, and model-based documentation, allowing users such as developers, project managers, and stakeholders to gain insights into interdependencies among technology, processes, and people. The software facilitates business capability mapping and risk management while ensuring compliance with data protection regulations. By providing a dynamic overview of projects and enabling contributions from across the organization, Ardoq supports digital transformation efforts and enhances decision-making processes.

Perfuze is a medical device company based in Galway, Ireland, founded in 2018 by Wayne Allen and Liam Mullins. Specializing in innovative catheter technology, Perfuze aims to treat acute ischemic stroke, a condition that can lead to severe health complications if not addressed promptly. The company’s technology is designed to improve clinical outcomes while reducing procedural times, making the treatment safer and more cost-effective for patients. With over 30 years of combined experience in the medtech industry, the founders are focused on developing solutions that minimize the need for alternative treatment options during procedures. Perfuze is currently located in the Business Innovation Centre at the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.

ViCentra B.V., based in Utrecht, the Netherlands, specializes in the development of medical devices, particularly for diabetes management. The company focuses on creating user-friendly and aesthetically pleasing products that aim to enhance the overall experience for individuals managing their health. ViCentra emphasizes the importance of excellent customer experiences and approaches product design with the belief that simplicity and effectiveness lead to better health outcomes. In addition to its operations in the Netherlands, ViCentra also has a presence in the UK, where it continues to innovate in the field of medical devices through dedicated research and development efforts.

Mambu GmbH is a Berlin-based software-as-a-service provider that specializes in banking solutions for managing credit and deposit products. Established in 2011, the company offers a comprehensive platform that enables financial institutions of all sizes, including fintech startups and traditional banks, to design, launch, and scale their banking portfolios. Mambu's services include loan product development, credit risk assessment, and document management, which enhance operational efficiency and data quality. Its platform supports over 7,000 products and serves more than eight million end customers across 46 countries. Additionally, Mambu facilitates features such as account opening, portfolio management, and task automation, thereby streamlining workflows for its clients. With offices in key global locations, Mambu is positioned to support a diverse range of financial institutions, from retail banks to microfinance organizations.

3Shape creates 3D scanners and CAD/CAM software solutions to improve patient care for dental and audiology professionals around the world.

AviadoBio mission is to transform the lives of people living with neurodegenerative disorders by developing and delivering transformative gene therapies for diseases including frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The Company’s technology is based on pioneering research from King’s College London and the UK Dementia Research Institute.

HotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment. The company's platform helps to identify hotspots and locate pathway treatments for cancer, metabolic and rare diseases, leverages a database of hotspot structures, harnessing the power of data science in its multidisciplinary approach to drug discovery enabling patients to get treatment against several diseases.

DNA Script SAS, founded in 2014 and based in Paris, France, specializes in synthetic biology tools and innovative DNA synthesis technology. The company has developed a groundbreaking enzymatic technology that powers the SYNTAX, the world's first benchtop DNA printer. This device allows laboratories to produce synthetic oligonucleotides on-site, significantly enhancing workflow control and expediting access to results. By employing an efficient biochemical process for nucleic acid synthesis, DNA Script enables researchers to rapidly generate essential genomic materials, such as oligonucleotides, which are crucial for genomics and molecular biology applications. Through its advancements, DNA Script aims to facilitate breakthroughs in life sciences and human health.

Egle Therapeutics SAS, a biotechnology company, develops immunotherapies targeting immune suppressor regulatory T-cells for oncology and autoimmune diseases. It develops Treg modulating drug pipeline, which includes computationally designed resurfaced IL-2 proprietary variants to engage or dis-engage Tregs. The company was founded in 2020 and is based in Paris, France.

They are the largest independent MGA in the UK. They provide their insurance products exclusively through authorised insurance brokers in over 60 countries around the world. Wholesale or retail, big or small, generalist or specialist, all of their brokers have access to underwriters who can make fast decisions and provide flexible solutions. By providing market-leading products, great service and configurable online systems, they help their brokers carry out business more easily, efficiently and profitably. That’s probably why they’ve won eight major industry awards in the last year and over 1,500 businesses move their insurance to CFC every month.

OneProjects Design and Innovation Ltd. develops healthcare technologies for the treatment of cardiac arrhythmias. It offers VERAFEYE, a connected platform technology to revolutionize the treatment of AFib and cardiac arrhythmias. The company was incorporated in 2017 and is based in Dublin, Ireland.

Cambridge Glycoscience is a biotechnology company based in London, United Kingdom, founded in 2017. The company specializes in developing sugar-free ingredients for the food industry, focusing on creating natural food components derived from agricultural resources. Their innovative products enable food manufacturers to reduce sugar content, enhance fiber levels, and improve gut health-promoting qualities in food items. By leveraging biotechnology, Cambridge Glycoscience aims to support healthier eating options and contribute to the evolving landscape of food production.

Made of Air specializes in the development of innovative biochar-based materials that aim to address climate change by permanently sequestering carbon dioxide. Composed of 90% atmospheric carbon, these sustainable materials serve as alternatives in various applications, including construction, interiors, and furniture. By generating negative carbon dioxide emissions, Made of Air's products enable real estate developers, architects, and municipalities to meet their climate goals effectively. The materials are not only customizable and formable but also recyclable, making them a versatile choice for environmentally conscious projects.

EC-Council Offers IT and e-Business certifications in CEH, CHFI, ECSP, ECIH, ECSA and LPT Programs EC-Council is the leading IT and e-Business certification awarding body and the creator of the world famous Certified Ethical Hacker (CEH), Computer Hacking Forensics Investigator (CHFI), EC-Council Certified Secure Programmer (ECSP), EC-Council Certified Incident Handler (ECIH) and EC-Council Certified Security Analyst (ECSA)/License Penetration Tester (LPT) programs. For a complete list of certifications, please visit http://cert.eccouncil.org. EC-Council has trained over 80,000 individuals and certified more than 30,000 security professionals from such fine organizations as the US Army, the FBI, Microsoft, IBM and the United Nations. EC-Council's certifications are recognized worldwide and have received endorsements from various government agencies including: - The US Federal Government via the Montgomery GI Bill, - National Security Agency (NSA) and the Committee on National Security Systems (CNSS). To learn more about EC-Council, please visit: www.eccouncil.org. Share Us At: Facebook: http://www.facebook.com/ECCouncil LinkedIn: http://www.linkedin.com/organization/ec-council

Amolyt Pharma is a clinical-stage biotechnology company focused on developing peptide-based therapies for rare endocrine and metabolic disorders. The company's leading programs include AZP-3601, a parathyroid hormone analog aimed at treating hypoparathyroidism by maintaining sustained calcium levels in the blood, and AZP-3404, which features a novel mechanism of action that may help restore fat and glucose metabolism. Through its innovative approach, Amolyt Pharma seeks to provide effective treatments for patients suffering from critical and rare metabolic conditions.

Blume Global Inc. is a technology company that specializes in developing a cloud-based digital platform designed to integrate and enhance global supply chains. This platform provides comprehensive solutions in asset management, logistics, visibility, optimization, and financial settlement, enabling clients to streamline their logistics processes. The platform offers features such as order management, multimodal booking, logistics execution, rate management, carrier selection, and asset tracking. Blume Global serves a diverse range of industries, including retail, consumer packaged goods, hi-tech, healthcare, life sciences, and automotive, catering to ocean carriers, logistics service providers, and asset owners. Founded in 1993 and headquartered in Pleasanton, California, the company also has a regional office in Hong Kong. It was previously known as REZ-1, Inc. before rebranding in 2018.

Formo, formerly known as LegenDairy Foods GmbH, is a Berlin-based company that pioneers the production of dairy products through biotechnology. As Europe's first cell-ag company, Formo specializes in creating real dairy products without the use of cows, employing innovative fermentation and bioprocess engineering techniques. The team consists of food scientists and engineers dedicated to advancing sustainable alternatives in the dairy industry. By leveraging biotechnology, Formo aims to provide consumers with high-quality dairy options while addressing environmental concerns associated with traditional dairy farming.

Formo, formerly known as LegenDairy Foods GmbH, is a Berlin-based company that pioneers the production of dairy products through biotechnology. As Europe's first cell-ag company, Formo specializes in creating real dairy products without the use of cows, employing innovative fermentation and bioprocess engineering techniques. The team consists of food scientists and engineers dedicated to advancing sustainable alternatives in the dairy industry. By leveraging biotechnology, Formo aims to provide consumers with high-quality dairy options while addressing environmental concerns associated with traditional dairy farming.

Storytel AB is a prominent provider of streaming services for audiobooks and e-books, operating under the brands Storytel and Mofibo. Founded in 2005 and headquartered in Stockholm, Sweden, the company has established a significant presence in various countries, including Denmark, Norway, Finland, the Netherlands, and Poland, among others. Storytel's business is divided into two main segments: Streaming and Publishing. The Streaming segment offers subscription-based access to a vast library of digital content, while the Publishing segment includes several well-known imprints such as Norstedts and Massolit, as well as children's and young adult literature through B. Wahlström and Rabén & Sjögren. Additionally, Storytel has expanded its offerings to include digital subscriptions for newspapers and magazines, enhancing its portfolio in the publishing sector.

Cardior Pharmaceuticals GmbH is a biotechnology company based in Hanover, Germany, established in 2016. The company specializes in developing non-coding RNA-based therapeutics aimed at treating and preventing heart disease, which is a leading cause of mortality in the western world. Its primary focus is on CDR-132X, an oligonucleotide-based inhibitor that targets a specific microRNA, which serves as a molecular master switch regulating pathological changes in the heart due to stress or injury. Cardior Pharmaceuticals is committed to discovering and clinically validating innovative therapies that address the underlying causes of cardiac dysfunction, ultimately striving to improve patients' health and quality of life.

Visus Therapeutics is a clinical-stage company focused on developing innovative ophthalmic therapies aimed at enhancing vision for individuals globally. The company is known for its presbyopia-correcting eye drops, which are designed to provide temporary relief from the loss of near vision associated with presbyopia. Additionally, Visus Therapeutics is engaged in the development of various ophthalmic product candidates targeting conditions such as ocular surface disease, glaucoma, and age-related macular degeneration. Through its research and product offerings, the company seeks to address significant unmet needs in vision care.

T-knife is a biotechnology company focused on developing T cell receptor therapies aimed at treating cancer. Utilizing a humanized T cell receptor (TCR) mice platform, the company is capable of carrying human TCRαβ gene loci and recombining a diverse array of human TCRs. This innovative approach facilitates the efficient generation and virtual selection of T cell receptors tailored for specific human tumor antigens, enhancing the potential for effective cancer therapies. Through its advanced technology, T-knife aims to improve treatment options for patients battling cancer.

Covanta Holding Corporation (Covanta) is a holding company. The Company is a owner and operator of infrastructure for the conversion of waste to energy ( energy-from-waste or EfW), as well as other waste disposal and renewable energy production businesses. Covanta conduct all of its operations through subsidiaries which are engaged predominantly in the businesses of waste and energy services. The Company has one segment which is Americas and consists of waste and energy services operations primarily in the United States and Canada. The Company owns and holds interests in energy-from-waste facilities in China and Italy. The Company also has investments in subsidiaries engaged in insurance operations in California, primarily in property and casualty insurance. In December 2013, the Company announced that it has acquired two transfer stations in Northern New Jersey from Advanced Disposal.

The blikk group is a growing network of radiological, nuclear medicine and nephrology practices using dialysis. As a reliable partner for patients and referring physicians, the practices of the association make a significant contribution to high-quality medical care. They all share the common claim to the highest quality and excellent education and training of medical and non-medical staff in all disciplines.

Provider of radiology and radiotherapy treatment services intended for imaging diagnostics. The company offers radiology diagnostics, therapy and radiation treatments for malignant and benign diseases as well as supports radiological and nuclear medicine practices as a financial investor and professional management partner on the path of succession planning, creating added value for doctors, employees, referrers and patients through central and local process optimization.

Xilis, Inc. is an oncology and precision health company that focuses on improving cancer diagnosis and treatment. Founded in 2019 and based in Chapel Hill, North Carolina, Xilis utilizes advanced organoid technologies, specifically micro-organoids, to create thousands of 3D replicas of a patient's tumor within six days. This innovative approach allows for rapid diagnostics and personalized drug screening, enabling healthcare providers to identify the most effective treatments for individual patients. The company's platform supports scalable, patient-derived models that facilitate high-throughput drug discovery, ultimately assisting physicians and pharmaceutical companies in developing tailored therapies at a reduced cost.

Cypress Creek Renewables is a leading American company specializing in local solar energy solutions. The firm employs a data-driven strategy to identify and acquire underutilized land for the development of solar farms, typically ranging from 2 to 20 megawatts. Notably, Cypress owns the largest solar farm east of the Mississippi River. The company partners with landowners, utility providers, and local vendors to develop, finance, and operate both utility-scale and distributed solar projects. In addition to generating renewable energy, Cypress offers asset management, fleet ownership, and maintenance services for its own and third-party solar and storage assets. By selling the electricity produced by its solar farms back to local communities at competitive rates, Cypress Creek Renewables ensures widespread access to clean and affordable energy.

PAREXEL International Corporation is a biopharmaceutical services company that supports the pharmaceutical, biotechnology, and medical device industries globally. Founded in 1983 and headquartered in Waltham, Massachusetts, the company operates through three main segments: Clinical Research Services (CRS), PAREXEL Consulting and Medical Communications Services (PCMS), and Perceptive Informatics. The CRS segment specializes in managing various aspects of clinical trials, including study design, patient recruitment, data management, and pharmacovigilance. The PCMS segment offers consulting services in areas such as drug development, regulatory affairs, and market access, assisting clients with product launch strategies and commercialization challenges. The Perceptive segment focuses on technology solutions, providing services like medical imaging, systems integration, and data management tools. By delivering a comprehensive range of services, PAREXEL aims to facilitate scientific discoveries and enhance the drug development process for its clients.

PRO Unlimited Inc. specializes in contingent workforce management solutions for Global and Fortune 500 companies. Founded in 1991 and headquartered in Boca Raton, Florida, the company addresses the complexities of managing temporary and independent workers, including contractors, consultants, and freelancers. PRO Unlimited offers a vendor-neutral Managed Services Program that assists clients in procurement, selection, engagement, and tracking of contingent labor. Its software-as-a-service platform, known as Vendor Management System (VMS), centralizes various aspects of workforce management, enabling organizations to control quality, manage costs, and ensure compliance. Additionally, the RatePoint application provides on-demand intelligence regarding rates and hiring for professional contingent positions. By focusing on issues such as supplier management, worker classification, lifecycle tracking, and co-employment, PRO Unlimited helps clients navigate the challenges associated with a growing contingent workforce. The company has expanded its presence internationally, with locations in the United Kingdom, Japan, California, New York, and Hong Kong.

Mollie B.V. is a payments platform that specializes in online payment processing for merchants. Founded in 2004 and headquartered in Amsterdam, the Netherlands, Mollie serves over 50,000 clients by providing an easy-to-implement solution for integrating various payment methods into websites and applications. The platform supports a wide range of local payment options, including Mastercard, VISA, PayPal, iDEAL, and Bitcoin, among others. Mollie focuses on simplifying the payment process for merchants, eliminating complexities associated with multiple payment methods through a powerful and user-friendly API. The company emphasizes technology, innovation, and reliability in its services.

Parcel2go.Com Ltd provides parcel delivery services in the United Kingdom. Its services includes myHermes ParcelShop; allows to drop off parcel at one of many outlets hence saving having to wait in for the driver to collect, DPD Drop-off; allows to drop parcel off at any of the DPD locations around the UK, UPS Standard; recognizes parcel couriers with brown vans and uniforms, Parcelforce Worldwide 48; allows to drop parcel in to a local Post Office, TNT UK Express, and Letters and Small Parcels by Whistl. The company was founded in 1991 and is based in Bolton, United Kingdom.

Solarpack focuses in the development and operation of large-scale photovoltaic solar projects. The company also has a consulting department that advises international customers in all areas of solar photovoltaic energy. The company global divisions which are development and construction, power generation, and services, represent an attractive and well-balanced combination of long term stable revenues with less recurrent yet highly profitable activities. It operates and maintains 13 plants, with a total capacity of 160 MW, and provides asset management services for a total of 302 MW of projects. The company also has a diversified geographical presence and employs over 140 people in 10 countries. Founded on 2005, Solarpack is a solid and solvent company, capable of executing quality and valuable projects for the society and the environment. It contributes directly to the social development of the communities and markets in which it operates, through the creation of economic value, and also through the generation of quality employment and through the social projects it promotes. It is headquartered in Getxo, Vizcaya in Spain.

Anticimex is a global specialist in preventive pest control with operations in 17 counties across Europe, Asia-Pacific and the US with headquarters in Stockholm, Sweden. With its approximately 4,500 employees, Anticimex serves more than 3 million customers across the globe and offers a broad range of preventive pest control solutions, including the digital solution Anticimex SMART and pest insurance.

Bought By Many is the multi-award-winning pet insurance provider that is disrupting insurance distribution. They do this by analysing anonymised internet search data and customer research to identify unmet consumer needs for insurance. Key company milestones are as follows: o 2012: Launched boughtbymany.com. Completed seed funding round. o 2013: Named Insurance Website of the Year. o 2014: Identified by Boston Consulting Group & Morgan Stanley as the global exemplar of innovation in insurance distribution. Awarded Best Use of Mobile Technology at the Digital Insurance Awards. o 2015: Surpassed 100,000 members. Launched SaaS platform in China in partnership with Ping An Insurance. Completed second funding round. Became directly regulated by the FCA. Acquired Brooks Braithwaite (Sussex) Ltd - the UK’s leading provider of insurance for exotic pets and pet businesses. Named Fintech Innovation of the Year & Insurance Start Up of the Year. o 2016: Innovation in Insurance Award at the Fintech Innovation Awards. Named in the FinTech 50. Signed long-term insurance agreement with Munich Re. Completed Series A funding round. o 2017: Launched Bought By Many-branded cat and dog insurance product range. o 2019: Named most trusted pet insurance provider at the 2019 Moneywise Customer Service Awards. Launched Bought By Many cat and dog insurance in Sweden. o 2020: Covers more than 200,000 pets in the UK. They have an exceptional team of 150, based across sites in Farringdon, Central London; Haywards Heath, Sussex; Birmingham; and Sweden. They're always interested to hear from people who'd like to learn about career opportunities at Bought By Many, and they're currently recruiting for web development, business analysis, & project management roles.

Founded in 1990, Desotec has pioneered the market for the purification of liquids and gases through mobile activated carbon filters. During its more than 25 years in business, the company has established itself as a European market leader in this field. Desotec provides a filtration technology that enables its customers to comply with increased environmental regulations and sustainability requirements and to serve mission-critical filtration needs offering a flexible rental solution.

Binx Health Limited is an in vitro diagnostics company based in Trowbridge, United Kingdom, specializing in the development of diagnostic instruments and disposable cartridge systems for decentralized laboratory and point-of-care environments. The company's flagship products include the io System, which detects infectious diseases such as chlamydia and MRSA, and Callisto, designed to accommodate various testing throughput requirements. Binx Health focuses on providing solutions for sexually transmitted infections and hospital-acquired infections. The company aims to enhance healthcare accessibility by delivering on-demand testing directly to consumers, utilizing its proprietary, desktop, PCR-based platforms and mobile offerings. Established in 2005, Binx Health has formed a strategic partnership with Sherlock Biosciences to further advance its innovative healthcare solutions.

Vinted is an online marketplace that focuses on making second-hand fashion a preferred choice for consumers. The platform facilitates a peer-to-peer environment where users, primarily women and girls, can buy, sell, and swap clothing, accessories, and lifestyle items. It features a mobile-first design and includes an online chatting option, allowing for seamless communication between users, which enhances the shopping experience while keeping costs low. Through its community-driven approach, Vinted aims to promote sustainable fashion practices by encouraging the reuse of clothing.

Manufacturer of food ingredients, food flavor and aroma chemicals for consumer products and nutraceuticals industries. The company offers essential oils, cheese powder, seasonings, botanical extracts, fruit juice powders, savory ingredients, serving flavors and fragrances industry all across the globe.

First Transit is a public transit management operator in North America, serving over 300 million passengers annually across approximately 300 locations. The company specializes in providing mobility services that include the operation, management, and consulting of passenger transportation and vehicle maintenance. Its clientele ranges from transit authorities and state departments of transportation to municipalities, universities, airports, and private companies. First Transit focuses on delivering economical, safe, and environmentally friendly transportation solutions for communities, college campuses, businesses, and elderly care facilities.

First Student, Inc. is a prominent school bus operator specializing in student transportation services for educational institutions across North America. The company focuses on providing safe and reliable rides to school, offering a range of services that include full-service and alternative transportation, consulting, electrification, and charter bus rentals. With a large fleet of buses, First Student caters to the home-to-school transportation needs of various school districts, ensuring that students have access to dependable and efficient transport options.

Onward is developing an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools to rehabilitate patients suffering from neurological disorders such as spinal cord injury (SCI).

Cerba HealthCare S.A.S., is a clinical pathology laboratory, provides routine and specialized clinical laboratory testing services.

Epidemic Sound is a Swedish based music company soundtracking the new generation of video creators. By working directly with composers and owning the music 100%, the company has built a model perfect for online video. Customers subscribe for unlimited use or license individual tracks. All music usage includes clearance on all platforms, worldwide, for all time. The company's catalogue has over 30 000 tracks, spaning over 180 genres, in prime time broadcast quality. Epidemic Sound was founded on 2009 and is headquartered in Stockholms, Sweden.

Cambridge Glycoscience is a biotechnology company based in London, United Kingdom, founded in 2017. The company specializes in developing sugar-free ingredients for the food industry, focusing on creating natural food components derived from agricultural resources. Their innovative products enable food manufacturers to reduce sugar content, enhance fiber levels, and improve gut health-promoting qualities in food items. By leveraging biotechnology, Cambridge Glycoscience aims to support healthier eating options and contribute to the evolving landscape of food production.

CYE provides innovative and cost effective cybersecurity solutions, combining for the first time advanced artificial intelligence with exceptional natural intelligence, along with services that are delivered by world leading security experts.

Provider of veterinary care services with clinics spread across Europe. The company has an expansive network of clinics, hospitals, and out-of-hour centers, thereby serving pet owners and guiding them on balanced nutrition for every animal, regardless of breed, age, and gender.

Exeter Property Group, established in 2006, is a real estate investment manager that specializes in U.S. investments in value-added and core properties. The company is led by a team with over 25 years of experience across various real estate market cycles. Exeter's investment strategy centers on assembling diversified property portfolios that cater to tenant needs for value and functionality. This approach aims to generate superior returns through high levels of cash flow, value-add growth, and capital appreciation potential. With regional offices throughout the U.S., Exeter employs a tenant-focused strategy that enables direct engagement in property selection and management.

Wolt is a Helsinki-based company that specializes in food delivery services, enabling users to conveniently discover and order meals for home or office delivery. The platform offers a mobile interface that facilitates access to a variety of dining options, including takeaway services. Since its inception, Wolt has attracted significant investment, raising $280 million from notable investors such as ICONIQ Capital, Highland Europe, 83North, EQT Ventures, and Goldman Sachs.

XyloCor Therapeutics, Inc. is a biopharmaceutical company focused on developing gene therapies for cardiovascular diseases, particularly advanced coronary artery disease. Established in 2013 and based in Newtown Square, Pennsylvania, the company is working on innovative treatments such as XC001, an investigational gene therapy aimed at patients suffering from refractory angina who have limited treatment options, and XC002, which targets cardiac tissue regeneration in individuals with compromised heart function due to past heart attacks. XyloCor's approach involves stimulating the formation of new coronary blood vessels to improve blood supply to areas of the heart that are inadequately perfused, thereby offering potential pain relief and improved outcomes for patients who have exhausted conventional pharmacologic therapies.

Neurent Medical Limited is a medical device company based in Galway, Ireland, specializing in the development of innovative treatments for rhinitis. Founded in 2015, the company has created a single-use, minimally invasive device designed for ENT surgeons to address both allergic and non-allergic rhinitis. This hand-held, radio-frequency device is introduced through the nostrils into the nasal cavity under direct endoscopic visualization. It employs a microelectrode array to deliver targeted energy, interrupting the autonomic function of the mucosal structures in the nasal cavities. This approach helps reverse the inflammatory cascade, allowing for effective treatment in an office setting while minimizing the complications and costs commonly associated with traditional surgical procedures.

Sitecore is a global software company that provides a unified platform for digital marketing and content management. It combines web content management, marketing automation, email marketing, social media integration, e-commerce, optimization, and analytics to enhance customer experiences across various digital channels. By enabling brands to deliver personalized content at scale and in real-time, Sitecore facilitates deeper connections between brands and their customers. The company's Experience Cloud supports marketers in managing every interaction and intention from customers, ensuring a cohesive digital experience. With over 3,500 customers worldwide, including major brands such as American Express and Microsoft, Sitecore also boasts a strong developer community with approximately 8,000 certified developers. The company has been recognized by Gartner as a leader in web content management for several consecutive years, highlighting its significant impact in the digital marketing landscape.

think project! is a cloud solution for cross-enterprise collaboration, tailored to the needs of construction and engineering projects. The name think project! stands for both a flexible software solution, which can be adapted to individual needs with little effort, and a team of specialists who implement cross-enterprise collaboration according to their customers’ individual requirements. think project! companies.

Storable is a provider of self-storage management software designed to enhance operational efficiency and profitability for storage operators. Its Storable Platform offers a comprehensive suite of technology solutions, including management software, marketing websites, tenant insurance, payment processing, and access to the industry's largest storage marketplace. This integrated approach allows customers to compare various storage options across the nation, enabling them to select the most suitable and cost-effective solutions for their needs, whether they require traditional self-storage or full-service storage options.

Molslinjen is a privately held company that provides ferry services between Jutland and Zealand in Denmark. The company operates a fleet of catamaran ferries designed for efficient marine transportation, featuring large car decks that allow for easy boarding and disembarking of vehicles such as cars, trucks, and buses. By focusing on fast and comfortable travel, Molslinjen aims to facilitate seamless transportation for passengers and freight across its domestic ferry lines.

Beijer Ref is a Sweden-based trading group that specializes in the distribution and servicing of refrigeration systems, air conditioning units, and heat pumps. The company provides value-added products to meet the needs of various sectors, including commercial refrigeration for food stores and shopping malls, industrial refrigeration for facilities like ice rinks and computer rooms, and comfort cooling for private residences and retail spaces. Beijer Ref primarily serves refrigeration installation contractors, service vendors, building companies, and manufacturers of refrigeration equipment. The majority of its sales occur within the European market, positioning the company as a key player in the region's refrigeration and air conditioning industry.

think project! is a cloud solution for cross-enterprise collaboration, tailored to the needs of construction and engineering projects. The name think project! stands for both a flexible software solution, which can be adapted to individual needs with little effort, and a team of specialists who implement cross-enterprise collaboration according to their customers’ individual requirements. think project! companies.

Livekindly, also known as LK, is a Vancouver-based media platform dedicated to promoting sustainable living through informative content related to health, ethics, and the environment. The company publishes news articles, press releases, and features that focus on plant-based lifestyles, including vegan recipes, restaurant recommendations, and family vacation ideas. Additionally, Livekindly operates Kindmind, a service offering plant-based meal plans, shopping guides, and expert consultations. The organization is committed to transforming the global food system by collaborating with innovative poultry production companies to develop plant-based alternatives. As part of its mission, Livekindly encompasses a collective of brands that includes The Fry Family Food Co. and LikeMeat, aiming to create delicious plant-based food while minimizing reliance on animal agriculture and natural resource depletion.

Cardiac Dimensions, Inc. is a medical device company focused on developing minimally invasive treatment options for heart failure and associated cardiovascular conditions. The company's primary product is the Carillon Mitral Contour System, a permanent implant designed to treat functional mitral regurgitation through a non-surgical, catheter-based approach. This innovative device reshapes the mitral valve to reduce regurgitation, enabling less invasive procedures for patients. Founded in 2000 and headquartered in Kirkland, Washington, Cardiac Dimensions also has operations in Sydney, Australia, and Offenbach, Germany.

Chr Hansen - Natural Colors is a developer and manufacturer of natural coloring ingredients for food and beverages.

Casa.it is a provider of online real estate advertising services. It offers information on real estate agencies, on sale, and for rent properties comprising of flats, villas, independent houses, penthouses, loft, and others, and private space on the internet. It was founded in 1996 and is headquartered in Milan, Italy.

Idealista is an online real estate portal operating in Spain, Italy, and Portugal, serving as a platform for agents and private individuals to connect. The website features over 280,000 unique property listings, providing valuable resources and guidance for both buyers and sellers. Since its inception in 2000, Idealista has focused on alleviating the challenges associated with finding a home, offering real-time property information to assist users in their transactions. The platform allows users to advertise their property portfolios in exchange for a recurring subscription fee, creating a comprehensive digital marketplace for real estate.

Colisée operates in the health care sector, focusing on the care and well-being of elderly individuals. The company manages a network of over 90 facilities across France, Italy, and Spain, along with nearly 70 home-based service agencies in France. Through these operations, Colisée provides nursing home and home care services, ensuring daily support for residents, patients, and their families. With a dedicated workforce exceeding 6,700 employees, Colisée is committed to delivering quality care tailored to the needs of its clients.

Depict.ai develops a product recommendation engine aimed at enhancing the quality of product suggestions for e-commerce stores. By providing advanced recommendation capabilities similar to those found on major platforms, the company enables smaller businesses to compete effectively against larger competitors. The software is designed to increase overall revenue for e-commerce sites without requiring extensive sales data, thereby democratizing access to high-quality recommendations. Through its innovative approach, Depict.ai seeks to empower smaller players in the e-commerce market, allowing them to improve customer engagement and drive sales.

Edge Services provide Space, Power & Connectivity to deliver digital content like never before. With EdgeConneX, data delivery is optimized by placing Edge Data Centers®, Edge Small Cells and Edge PoPs® at the most critical locations—as close as possible to the end user’s point of access. By using our services, digital content is delivered with higher performance and lower latency to any device, anywhere.

DNA Script SAS, founded in 2014 and based in Paris, France, specializes in synthetic biology tools and innovative DNA synthesis technology. The company has developed a groundbreaking enzymatic technology that powers the SYNTAX, the world's first benchtop DNA printer. This device allows laboratories to produce synthetic oligonucleotides on-site, significantly enhancing workflow control and expediting access to results. By employing an efficient biochemical process for nucleic acid synthesis, DNA Script enables researchers to rapidly generate essential genomic materials, such as oligonucleotides, which are crucial for genomics and molecular biology applications. Through its advancements, DNA Script aims to facilitate breakthroughs in life sciences and human health.

Vico Therapeutics B.V. is a biotechnology company based in Leiden, the Netherlands, founded in 2019. It specializes in developing RNA modulating therapies aimed at treating rare neurological disorders. The company's primary focus includes spinocerebellar ataxias, Huntington's disease, and Rett syndrome, which are characterized by progressive neurological decline and developmental challenges. Vico Therapeutics is committed to discovering and delivering innovative treatments that address the unmet medical needs of patients suffering from these severe conditions. Through its research and development efforts, the company seeks to provide effective therapeutic options for individuals affected by these disorders.

VarmX B.V., a biotechnology company, develops therapies in the field of hemostasis and thrombosis. It develops PseudoXa, a therapeutic protein that is used to stop bleeding of patients who use blood thinners. The company was founded in 2016 and is based in Leiden, the Netherlands.

ViCentra B.V., based in Utrecht, the Netherlands, specializes in the development of medical devices, particularly for diabetes management. The company focuses on creating user-friendly and aesthetically pleasing products that aim to enhance the overall experience for individuals managing their health. ViCentra emphasizes the importance of excellent customer experiences and approaches product design with the belief that simplicity and effectiveness lead to better health outcomes. In addition to its operations in the Netherlands, ViCentra also has a presence in the UK, where it continues to innovate in the field of medical devices through dedicated research and development efforts.

Cybin is a biopharmaceutical company dedicated to developing safe and effective therapeutics using psychedelic and medicinal mushrooms. The company focuses on creating psilocybin-based products in regions where such substances are permitted, while also conducting clinical studies across North America and other areas through collaborations with academic and institutional partners. Cybin's efforts encompass the advancement of psychedelic-based therapies, innovative delivery mechanisms, and the development of novel compounds aimed at addressing a range of mental health issues, including various psychiatric and neurological conditions.

OneProjects Design and Innovation Ltd. develops healthcare technologies for the treatment of cardiac arrhythmias. It offers VERAFEYE, a connected platform technology to revolutionize the treatment of AFib and cardiac arrhythmias. The company was incorporated in 2017 and is based in Dublin, Ireland.

Freepik is a digital platform based in Malaga, Spain, that serves as a search engine for graphic and web designers seeking high-quality visual content. The platform offers a comprehensive database of illustrations, photos, vectors, icons, mock-ups, and presentation templates, facilitating easy access to a wide range of graphic resources. By organizing and displaying free graphic content found across the internet, Freepik simplifies the process for users to locate the files they need for their creative projects, such as websites, banners, magazines, and advertisements.

Arvelle Therapeutics GmbH is a biopharmaceutical company based in Zug, Switzerland, founded in 2019. The company focuses on developing and commercializing innovative treatments for patients with central nervous system (CNS) disorders. Its primary product is cenobamate, an investigational antiepileptic drug aimed at providing effective solutions for patients suffering from focal seizures. By targeting debilitating neurological and neuromuscular diseases, Arvelle Therapeutics aims to enhance the quality of care available to clinicians and their patients.

Kiadis Pharma N.V. is a biopharmaceutical company based in Amsterdam, specializing in cell-based immunotherapy products for blood cancer treatment. The company is developing K-NK002, currently in Phase II clinical trials, as an adjunctive immunotherapeutic for blood cancer patients undergoing haploidentical hematopoietic stem cell transplantation with the post-transplant cyclophosphamide protocol. K-NK003 is another product in Phase I/II trials, targeting patients with acute myeloid leukemia relapse or refractory cases. Additionally, Kiadis Pharma is working on K-NK00X, a preclinical NK-cell therapy candidate aimed at treating various solid tumors. The company has established collaborations for the development of a combination therapy involving monoclonal antibodies and natural killer cells to address COVID-19. Kiadis Pharma focuses on addressing the complications and limitations associated with hematopoietic stem cell transplants, offering novel treatment options for terminally ill cancer patients with significant unmet medical needs.

FoRx Therapeutics AG is a biotechnology company based in Basel, Switzerland, founded in 2019. It specializes in developing innovative therapeutics for cancer treatment by targeting key molecular pathways involved in DNA replication stress. The company aims to create first-in-class compounds that represent a novel approach in the fight against cancer, focusing on drugging specific molecular targets associated with this replication stress. Through its research and development efforts, FoRx Therapeutics seeks to contribute to the advancement of targeted anticancer drugs within the healthcare industry.

Schülke & Mayr GmbH is a company that develops, manufactures, and supplies a diverse range of hygiene and care products, including disinfectants, antiseptics, preservatives, biocides, and medical skin care items. Founded in 1889 and headquartered in Norderstedt, Germany, the company serves various sectors, offering specialized hygiene management solutions aimed at preventing hospital-acquired infections, as well as professional hygiene products for medical practices and outpatient facilities. Its industrial hygiene solutions cater to industries such as food processing and pharmaceuticals, while its preservatives are used in cosmetics, household products, coatings, and metalworking. Schülke & Mayr GmbH operates globally with subsidiaries in multiple countries, including Australia, France, India, and the United States, and functions as a subsidiary of L'Air Liquide S.A.

Dukes Education is a university preparation provider that supports students of all ages to develop academic excellence.

Deutsche Glasfaser Holding GmbH, established in 2012 and headquartered in Borken, Germany, specializes in operating fiber optic networks and delivering broadband telecommunication services. The company focuses on expanding high-speed internet access, particularly in underserved areas of Germany. As of May 2020, Deutsche Glasfaser operates as a subsidiary of inexio Beteiligungs GmbH & Co. KGaA, reflecting its strategic alignment within a larger telecommunications framework.

RIMES Technologies provide specialist managed data services to investment managers and asset owners worldwide. They deliver cloud-based services that help our clients reduce the cost of managing financial data while lowering operational risk. With 20 years’ experience, no one knows as much about financial benchmarks as we do. They are the world’s first managed data service provider for investment managers and asset owners, and a trusted partner to our customers.

O2 Power Private Limited develop and execute utility scale renewable energy project. The company was incorporated in 2019 and is based in Gurugram, India.

Health Management International Ltd is a regional private healthcare provider operating in Singapore, Malaysia, and Indonesia. The company owns two tertiary hospitals in Malaysia and a healthcare training center in Singapore, alongside a network of representative offices across the three countries. It focuses on delivering a range of medical services, including cardio-vascular care, digestive health treatments, minimally invasive surgeries, and diagnostic services. This comprehensive approach aims to cater to both local and international patients, ensuring access to high-quality medical care.

SHL Group, based in Zug, Switzerland, specializes in the design, development, and manufacturing of advanced drug delivery systems, including auto injectors, pen injectors, and inhaler systems. Founded in 1989, the company provides comprehensive services, such as final assembly, labeling, and packaging, for pharmaceutical and biotech firms globally. SHL Group prioritizes compliance with strict regulations and upholds high-quality standards in its operations. The company emphasizes the importance of talent development and collaboration among its employees to enhance productivity and customer satisfaction. By focusing on these core principles, SHL Group aims to deliver superior business outcomes while maintaining professionalism in all aspects of its work.

Recover Nordic Norge is the largest emergency response and damage control business in the Nordic region.

Mabtech AB is a biotechnology company based in Stockholm, Sweden, founded in 1986. The company specializes in the development, manufacturing, and marketing of monoclonal antibodies and various assay kits, including those for enzyme-linked immunoassays such as ELISA, ELISpot, and FluoroSpot. Mabtech's product range includes monoclonal antibodies for a variety of applications, as well as specialized kits for detecting cytokines and other immunological molecules in biological samples from multiple species, including humans and various animals. The company aims to support the global scientific community by providing efficient tools that streamline the biomedical research process. Mabtech operates internationally, with locations in the United States, Australia, Germany, and France, and offers its products online. It is a subsidiary of Mabtech Group AB.

ImCheck Therapeutics SAS is a biopharmaceutical company based in Marseille, France, founded in 2015. The company specializes in the development of immunotherapeutics aimed at addressing severe unmet medical needs, primarily in the field of immuno-oncology. ImCheck focuses on creating immuno-modulatory antibodies that target members of the butyrophilin super-family of checkpoint molecules, specifically engaging γ9δ2 T cells. Its research and development efforts are directed toward treating various cancers, including breast, gastric, and ovarian cancers, as well as other immune-related diseases. The company's innovative approach positions it at the forefront of next-generation immunotherapy solutions for patients suffering from solid tumors.

Galderma S.A. is a global company specializing in the manufacture and distribution of medical, consumer skin health, and dermatology products. Founded in 1981 and headquartered in Lausanne, Switzerland, Galderma offers a wide range of solutions including prescription medicines, medical aesthetics, and skincare products. Its extensive product portfolio addresses various dermatological conditions such as acne, rosacea, psoriasis, and skin cancer, with well-known brands like Epiduo®, Differin®, and Restylane®. The company operates through a network of 33 wholly-owned affiliates and distributors in approximately 80 countries, employing around 6,600 people. Galderma emphasizes innovation in meeting the dermatological needs of individuals and healthcare professionals, with research and development, and manufacturing sites located across multiple regions including Europe, Asia-Pacific, and the Americas.

Inexio is a technology company that specializes in telecommunications and information technology services, focusing on fiber-based internet access for corporations and medium-sized businesses. The company provides broadband connections through a fiber-optic network and is actively involved in the development and expansion of modern telecommunications infrastructure. Inexio also offers data center services, supporting businesses in their IT needs and enhancing connectivity and operational efficiency.

CTEK Sweden AB is a prominent manufacturer of battery chargers, specializing in 12V chargers for a range of vehicles in the premium segment. The company stands as Sweden's second largest supplier of chargers and accessories for electric vehicle charging, highlighting its significant role in the evolving automotive market. With a focus on delivering high-quality products, CTEK is recognized for its innovative solutions that cater to the needs of both conventional and electric vehicle users.

Pharvaris B.V. is a clinical-stage company based in Leiden, the Netherlands, focused on the discovery and development of oral bradykinin B2 receptor antagonists for the treatment of hereditary angioedema (HAE) and other conditions linked to B2 receptor activity. Established in 2015, the company aims to provide new therapeutic options that eliminate the need for injections. Its lead drug candidate, PHA121, is a novel small-molecule antagonist currently undergoing Phase 1 clinical trials. Pharvaris benefits from the expertise of its co-founders, including an inventor of icatibant, which is a previously developed treatment for HAE. The company is dedicated to advancing alternatives to existing therapies, enhancing the quality of life for patients with HAE.

Nkarta Therapeutics is a biopharmaceutical company focused on developing engineered natural killer (NK) cell therapies for cancer treatment. Founded in 2015 and headquartered in South San Francisco, California, Nkarta aims to enhance the efficacy and tolerability of cell therapies, addressing both hematologic and solid tumor malignancies. The company's approach utilizes chimeric antigen receptors on NK cells, enabling them to recognize and attack tumor cells more effectively. Nkarta's lead product candidates include NKX101, designed to harness innate NK cell biology for cancer detection and destruction, and NKX019, targeting the CD19 antigen to treat various B cell malignancies. By leveraging its NK expansion platform and proprietary cell engineering technologies, Nkarta seeks to provide a more potent and accessible treatment option, capitalizing on the natural ability of NK cells to identify and eliminate abnormal cells while minimizing side effects typically associated with other therapies.

Ellab is a global supplier of thermal validation and monitoring solutions, specializing in wireless data loggers and thermocouple systems. The company provides a range of high-precision, modular products designed to measure, record, monitor, and validate critical parameters in thermal processing. Its offerings include data loggers, thermocouple-based instruments, and validation equipment, which are utilized in various applications such as sterilization, freeze-drying, environmental chambers, heat tunnels, and pasteurization. Operating in over 65 countries, Ellab focuses on reducing time-to-market and minimizing the risk of product loss for its clients.

Nexon Asia Pacific Pty. Ltd. is an end-to-end managed IT provider based in Sydney, Australia, with additional offices in Brisbane and Summer Hill. Established in 2000, the company offers a comprehensive range of information technology consulting and solutions, focusing on voice and communications, network management, infrastructure, business continuity, and security. Its voice and communications solutions include PBX, contact center technology, and video conferencing, while network solutions encompass managed private networks, business Internet, and WAN optimization. The company also provides infrastructure services such as infrastructure-as-a-service and storage-as-a-service, alongside business continuity solutions like backup and disaster recovery services. Security offerings include managed firewalls and intrusion prevention systems. Nexon Asia Pacific serves various sectors, including aged care, healthcare, government, legal services, and retail, delivering its products and services through a network of resellers and partners.

Alizé Pharma is a group of privately held biopharmaceutical companies specializing in the development of innovative biopharmaceutical drugs, proteins, and peptides, for the treatment of metabolic diseases and cancer. It is based in Ecully, near Lyon, France. Its management is made up of a team of drug development experts and a board of directors offering wide international experience. Alizé Pharma has two programs, the AZP-3601, a PTH analog for hypoparathyroidism, and AZP-3404, a peptide leveraging the biology of IGFBP2 for the treatment of syndromes of acute insulin resistance. The company was founded on 2015.

Aldevron, LLC is a contract science organization based in Fargo, North Dakota, that specializes in the production of biological products, including plasmid DNA, proteins, antibodies, and nucleic acids. Founded in 1998, the company serves academic, research institutions, and the pharmaceutical and biotechnology sectors, focusing on applications in gene therapy and gene editing. Aldevron offers a range of services such as plasmid DNA production, protein production, antibody discovery, and mRNA production, as well as custom manufacturing solutions. Its products support various research and clinical applications, including DNA vaccines and therapeutic gene transfer studies. The company also provides additional services like gene synthesis, antibody processing, and stability services for distribution. Aldevron operates both in the United States and Europe, contributing to the development of innovative treatments for diseases, including cancer and rare disorders.

Waystar is a provider of cloud-based technology that streamlines the healthcare revenue cycle for various organizations, including providers, hospitals, and health systems. The platform enhances data integrity and improves the accuracy of claims and billing processes, facilitating better transparency and reducing labor costs. By simplifying the complexities involved in healthcare payments, Waystar enables clients to focus on their core missions and patient care. The company has received multiple accolades, including Best in KLAS® rankings for claims clearinghouse and top ratings for medical claims processing and patient payment solutions. Serving over 400,000 healthcare organizations, Waystar partners with leading electronic health record and practice management solution providers to deliver comprehensive and efficient services across the United States and its territories.

AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derived peptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.